Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. | Cancers (Basel) | 2022 | 35740618 | PubTator, text mining | PubMed |
| Identification of LOC101927355 as a Novel Biomarker for Preeclampsia. | Biomedicines | 2022 | 35740273 | PubTator, text mining | PubMed |
| LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression. | Noncoding RNA | 2022 | 35736633 | PubTator, text mining | PubMed |
| Hypoxia induced-disruption of lncRNA TUG1/PRC2 interaction impairs human trophoblast invasion through epigenetically activating Nodal/ALK7 signalling. | J Cell Mol Med | 2022 | 35729773 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star. | Cell Biosci | 2022 | 35729650 | PubTator, text mining | PubMed |
| Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty. | NPJ Precis Oncol | 2022 | 35729321 | PubTator, text mining | PubMed |
| LncRNA UCA1 epigenetically suppresses APAF1 expression to mediate the protective effect of sevoflurane against myocardial ischemia-reperfusion injury. | Funct Integr Genomics | 2022 | 35723795 | PubTator, text mining | PubMed |
| Role of different non-coding RNAs as ovarian cancer biomarkers. | J Ovarian Res | 2022 | 35715825 | PubTator, text mining | PubMed |
| Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression. | Biomed J | 2022 | 35715331 | PubTator, text mining | PubMed |
| A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma. | Comput Biol Med | 2022 | 35715263 | PubTator, text mining | PubMed |
| The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC). | Front Oncol | 2022 | 35712512 | PubTator, text mining | PubMed |
| Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer. | Sci Rep | 2022 | 35710698 | PubTator, text mining | PubMed |
| Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors. | World J Surg Oncol | 2022 | 35710427 | PubTator, text mining | PubMed |
| lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway. | Bioengineered | 2022 | 35703318 | PubTator, text mining | PubMed |
| The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer. | Front Oncol | 2022 | 35692795 | PubTator, text mining | PubMed |
| LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis. | Front Oncol | 2022 | 35692742 | PubTator, text mining | PubMed |
| CRISPR-Cas technology a new era in genomic engineering. | Biotechnol Rep (Amst) | 2022 | 35686011 | PubTator, text mining | PubMed |
| Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction. | Pathol Oncol Res | 2022 | 35685867 | PubTator, text mining | PubMed |
| Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery. | Int J Mol Sci | 2022 | 35682901 | PubTator, text mining | PubMed |
| SNHG22 promotes migration and invasion of trophoblasts via miR-128-3p/PCDH11X axis and activates PI3K/Akt signaling pathway. | Clinics (Sao Paulo) | 2022 | 35679761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=42